Luteinizing hormone levels are positively correlated with plasma amyloid-β protein levels in elderly men

Journal of Alzheimer's Disease

Volumn 14, Issue 2, 2008, Pages 201-208

  Verdile, Giuseppe ^a,b,c   Yeap, Bu B ^d,e   Clarnette, Roger M ^a,b,e   Dhaliwal, Satvinder ^f   Burkhardt, Melanie S ^a,b,g   Chubb, S A Paul ^e   De Ruyck, Karl ^a,b   Rodrigues, Mark ^a,b   Mehta, Pankaj D ^h   Foster, Jonathan K ^a,b   Bruce, David G ^d,e   Martins, Ralph N ^a,b,c  

^a EDITH COWAN UNIVERSITY   (Australia)

^b HOLLYWOOD PRIVATE HOSPITAL   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^e FREMANTLE HOSPITAL   (Australia)

^f CURTIN UNIVERSITY   (Australia)

^g MURDOCH UNIVERSITY   (Australia)

^h NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

Alzheimer's disease; Amyloid ; Cognition; Luteinizing hormone; Testosterone

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; LUTEINIZING HORMONE; TESTOSTERONE;

ADULT; AGED; ARTICLE; BODY MASS; COGNITION; CONTROLLED STUDY; CORRELATION ANALYSIS; ELDERLY CARE; HORMONE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; MALE; MULTIPLE LINEAR REGRESSION ANALYSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

EID: 47849116727     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2008-14208     Document Type: Article

References (45)

1. O.P. Almeida, A. Waterreus, N. Spry, L. Flicker and R.N. Martins, One year follow-up study of the association between chemical castration, sex hormones, beta-amyloid, memory and depression in men, Psychoneuroendocrinology 29 (2004), 1071-1081.
2. A. Assini, S. Cammarata, A. Vitali, M. Colucci, L. Giliberto, R. Borghi, M.L. Inglese, S. Volpe, S. Ratto, F. Dagna-Bricarelli, C. Baldo, A. Argusti, P. Odetti, A. Piccini and M. Tabaton, Plasma levels of amyloid beta-protein 42 are increased in women with mild cognitive impairment, Neurology 63 (2004), 828-831.
3. K.D. Bagshawe, A.H. Orr and A.G. Rushworth, Relationship between concentrations of human chorionic gonadotrophin in plasma and cerebrospinal fluid, Nature 217 (1968), 950-951.
4. K. Balakrishnan, G. Verdile, P.D. Mehta, J. Beilby, D. Nolan, D.A. Galvão, R. Newton, S. Gandy and R.N. Martins, Plasma Abeta42 correlates positively with increased body fat in healthy individuals, J Alzheimers Dis 8 (2005), 269-282.
5. E. Barrett-Connor, D. Goodman-Gruen and B. Patay, Endogenous sex hormones and cognitive function in older men, J Clin Endocrinol Metab 84 (1999), 3681-3685.
6. R.D. Bell, A.P. Sagare, A.E. Friedman, G.S. Bedi, D.M. Holtzman, R. Deane and B.V. Zlokovic, Transport pathways for clearance of human Alzheimer's amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system, J Cereb Blood Flow Metab 27 (2007), 909-918.
7. R.L. Bowen, J.P. Isley and R.L. Atkinson, An association of elevated serum gonadotropin concentrations and Alzheimer disease? J Neuroendocrinol 12 (2000), 351-354.
8. R.L. Bowen, M.A. Smith, P.L. Harris, Z. Kubat, R.N. Martins, R.J. Castellani, G. Perry and C.S. Atwood, Elevated luteinizing hormone expression colocalizes with neurons vulnerable to Alzheimer's disease pathology, J Neurosci Res 70 (2002), 514-518.
9. R.L. Bowen, G. Verdile, T. Liu, A.F. Parlow, G. Perry, M.A. Smith, R.N. Martins and C.S. Atwood, Luteinizing hormone, a reproductive regulator that modulates the processing of amyloid-beta precursor protein and amyloid-beta deposition, J Biol Chem 279 (2004), 20539-20545.
10. M.S. Burkhardt, J.K. Foster, R.M. Clarnette, S.A.P. Chubb, D.G. Bruce, P.D. Drummond, R.N. Martins and B.B. Yeap, Interaction between testosterone and APOE genotype on cognition in healthy older men: The Fremantle Endocrinology of Ageig Research Study, J Clin Endocrinol Metab 91 (2005), 1168-1172.
11. M. Carruthers, ADAM: Androgen Deficiency in the Adult Male- Causes, Diagnosis and Treatment, Taylor and Francis, London, New York, 2004.
12. G. Casadesus, K.M. Webber, C.S. Atwood, M.A. Pappolla, G. Perry, R.L. Bowen and M.A. Smith, Luteinizing hormone modulates cognition and amyloid-beta deposition in Alzheimer APP transgenic mice, Biochim Biophys Acta 1762 (2006), 447-452.
13. M.L. Cawood, H.P. Field, C.G. Ford, S. Gillingwater, A. Kicman, D. Cowan and J.H. Barth, Testosterone measurement by isotope-dilution liquid chromatography-tandem mass spectrometry: validation of a method for routine clinical practice, Clin Chem 51 (2005), 1472-1479.
14. S. Chakravarti, W.P. Collins, J.D. Forecast, J.R. Newton, D.H. Oram and J.W. Studd, Hormonal profiles after the menopause, Br Med J 2 (1976), 784-787.
15. B. Couzinet, M. Pholsena, J. Young and G. Schaison, The impact of a pure anti-androgen (flutamide) on LH, FSH, androgens and clinical status in idiopathic hirsutism, Clin Endocrinol (Oxf) 39 (1993), 157-162.
16. M.F. Folstein, S.E. Folstein and P.R. McHugh, "Mini-mental state", A practical method for grading the cognitive state of patients for the clinician, J Psychiatr Res 12 (1975), 189-198.
17. H. Fukumoto, M. Tennis, J.J. Locascio, B.T. Hyman, J.H. Growdon and M.C. Irizarry, Age but not diagnosis is the main predictor of plasma amyloid beta-protein levels, Arch Neurol 60 (2003), 958-964.
18. M.J. Gillett, R.N. Martins, R.M. Clarnette, S.A. Chubb, D.G. Bruce and B.B. Yeap, Relationship between testosterone, sex hormone binding globulin and plasma amyloid beta peptide 40 in older men with subjective memory loss or dementia, J Alzheimers Dis 5 (2003), 267-269.
19. S. Goodenough, S. Engert and C. Behl, Testosterone stimulates rapid secretory amyloid precursor protein release from rat hypothalamic cells via the activation of the mitogen-activated protein kinase pathway, Neurosci Lett 296 (2000), 49-52.
20. G.K. Gouras, H. Xu, R.S. Gross, J.P. Greenfield, B. Hai, R. Wang and P. Greengard, Testosterone reduces neuronal secretion of Alzheimer's beta-amyloid peptides, Proc Natl Acad Sci USA 97 (2000), 1202-1205.
21. J.E. Hixson and D.T. Vernier, Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI, J Lipid Res 31 (1990), 545-548.
22. E. Hogervorst, J.Williams, M. Budge, L. Barnetson, M. Combrinck and A.D. Smith, Serum total testosterone is lower in men with Alzheimer's disease, Neuro Endocrinol Lett 22 (2001), 163-168.
23. E. Hogervorst, D.J. Lehmann, D.R. Warden, J. McBroom and A.D. Smith, Apolipoprotein E epsilon4 and testosterone interact in the risk of Alzheimer's disease in men, Int J Geriatr Psychiatry 17 (2002), 938-940.
24. E. Hogervorst, M. Combrinck and A.D. Smith, Testosterone and gonadotropin levels in men with dementia, Neuro Endocrinol Lett 24 (2003), 203-208.
25. E. Hogervorst, S. Bandelow, M. Combrinck and A.D. Smith, Low free testosterone is an independent risk factor for Alzheimer's disease, Exp Gerontol 39 (2004), 1633-1639.
26. E. Hogervorst, C. De Jager, M. Budge and A.D. Smith, Serum levels of estradiol and testosterone and performance in different cognitive domains in healthy elderly men and women, Psychoneuroendocrinology 29 (2004), 405-421.
27. H. Lukacs, E.S. Hiatt, Z.M. Lei and C.V. Rao, Peripheral and intracerebroventricular administration of human chorionic gonadotropin alters several hippocampus-associated behaviors in cycling female rats, Horm Behav 29 (1995), 42-58.
28. R. Mayeux, M.X. Tang, D.M. Jacobs, J. Manly, K. Bell, C. Merchant, S.A. Small, Y. Stern, H.M. Wisniewski and P.D. Mehta, Plasma amyloid beta-peptide 1-42 and incipient Alzheimer's disease, Ann Neurol 46 (1999), 412-416.
29. P.D. Mehta, A.J. Dalton, S.P. Mehta, K.S. Kim, E.A. Sersen and H.M.Wisniewski, Increased plasma amyloid beta protein 1-42 levels in Down syndrome, Neurosci Lett 241 (1998), 13-16.
30. P.D. Mehta, T. Pirttila, S.P. Mehta, E.A. Sersen, P.S. Aisen and H.M. Wisniewski, Plasma and cerebrospinal fluid levels of amyloid beta proteins 1-40 and 1-42 in Alzheimer disease, Arch Neurol 57 (2000), 100-105.
31. J.E. Morley, F.E. Kaiser, H.M. Perry, P. Patrick, P.M.K. Morley, P.M. Stauber, B. Vellas, R.N. Baumgartner and P.J. Garry, Longitudinal changes in testotserone, luteinizing hormone, and follicle-stimulating hormone in older men, Metabolism 46 (1996), 410-413.
32. J. Naslund, V. Haroutunian, R. Mohs, K.L. Davis, P. Davies, P. Greengard and J.D. Buxbaum, Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline, Jama 283 (2000), 1571-1577.
33. P. Odetti, A. Piccini, L. Giliberto, R. Borghi, A. Natale, F. Monacelli, M. Marchese, A. Assini, M. Colucci, S. Cammarata and M. Tabaton, Plasma levels of insulin and amyloid beta 42 are correlated in patients with amnestic Mild Cognitive Impairment, J Alzheimers Dis 8 (2005), 243-245.
34. C.J. Pike, Testosterone attenuates beta-amyloid toxicity in cultured hippocampal neurons, Brain Res 919 (2001), 160-165.
35. E.R. Rosario, L. Chang, F.Z. Stanczyk and C.J. Pike, Age-related testosterone depletion and the development of Alzheimer disease, Jama 292 (2004), 1431-1432.
36. M. Roth, E. Tym, C.Q. Mountjoy, F.A. Huppert, H. Hendrie, S. Verma and R. Goddard, CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia, Br J Psychiatry 149 (1986), 698-709.
37. M. Shibata, S. Yamada, S.R. Kumar, M. Calero, J. Bading, B. Frangione, D.M. Holtzman, C.A. Miller, D.K. Strickland, J. Ghiso and B.V. Zlokovic, Clearance of Alzheimer's amyloidss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier, J Clin Invest 106 (2000), 1489-1499.
38. R.A. Short, R.L. Bowen, P.C. O'Brien and N.R. Graff-Radford, Elevated gonadotropin levels in patients with Alzheimer disease, Mayo Clin Proc 76 (2001), 906-909.
39. C.C. Smith and D.J. Betteridge, Plasma beta-amyloid (A beta) 40 concentration, lipid status and age in humans, Neurosci Lett 367 (2004), 48-50.
40. M. van Oijen, A. Hofman, H.D. Soares, P.J. Koudstaal and M.M. Breteler, Plasma Abeta(1-40) and Abeta(1-42) and the risk of dementia: a prospective case-cohort study, Lancet Neurol 5 (2006), 655-660.
41. A. Vermeulen, Environment, human reproduction, menopause, and andropause, Environ Health Perspect 101(Suppl 2) (1993), 91-100.
42. A.Vermeulen, L. Verdonck and J.M. Kaufman, A critical evaluation of simple methods for the estimation of free testosterone in serum, J Clin Endocrinol Metab 84 (1999), 3666-3672.
43. P.R. Wenham, W.H. Price and G. Blandell, Apolipoprotein E genotyping by one-stage PCR, Lancet 337 (1991), 1158-1159.
44. A.C. Wilson, M.S. Salamat, R.J. Haasl, K.M. Roche, A. Karande, S.V. Meethal, E. Terasawa, R.L. Bowen and C.S. Atwood, Human neurons express type I GnRH receptor and respond to GnRH I by increasing luteinizing hormone expression, J Endocrinol 191 (2006), 651-663.
45. B.B.Yeap, O.P. Almeida, Z. Hyde, P.E. Norman, S.A.P. Chubb and K. Jamrozik, In men older than 70 years, total testosterone remains stable while free testosterone declines with age. The health in men study, Eur J of Endocrinol 156 (2007), 585-594.